Profile cover photo
Profile photo
Fred Hutch
196 followers -
The mission of Fred Hutchinson Cancer Research Center is the elimination of cancer and related diseases as causes of human suffering and death.
The mission of Fred Hutchinson Cancer Research Center is the elimination of cancer and related diseases as causes of human suffering and death.

196 followers
About
Posts

Post has attachment
Today's milestone U.S. Food and Drug Administration approval of immunotherapy drug CTL019 as a treatment for advanced cases of leukemia in children and young adults validates the importance of similar lifesaving cellular immunotherapies being developed and tested by Fred Hutch and other National Cancer Institute-designated cancer centers, and highlights the need for continued partnership, investment and government funding.

“Although narrow in scope, today’s FDA ruling is a milestone," says Dr. David Maloney, medical director of cellular immunotherapy at Fred Hutch. "This is the first approval for the use of genetically engineered immune cells as a treatment for cancer and is an important validation of technical advances under way in the field of cellular immunotherapy where we are modifying cells from a patient’s own immune systems to seek out and eliminate cancer cells. We at the Fred Hutchinson Cancer Research Center believe this is just the first of what will soon be many new immunotherapy-based treatments for a variety of cancers."

Post has attachment
Kudos to Mary Potts, Fred Hutch’s Cancer Surveillance System guru, who received an award for distinguished service from the North American Association of Central Cancer Registries. She was honored “for her significant contributions to improvements in registry operations, data quality and the development of educational tools that have benefited the cancer surveillance community.”

Fred Hutch’s Cancer Surveillance System, or CSS, collects population-based data on cancer incidence and survival in 13 counties in western Washington state, providing public health scientists and health care practitioners with the ability to track trends in the incidence of all forms of cancer, identify and investigate patterns of cancer occurrence, and monitor trends in mortality and survival for specific cancers.

Post has attachment
With the sun out and temps up, these two young supporters, Eliza and Greta Brooks, asked their parents if they could set up a lemonade stand to raise money for Fred Hutch. We couldn't be more proud of you girls. Thank you, and keep up the good work!
Photo

Post has attachment
Congrats to Fred Hutch’s Dr. Sunil Hingorani, who has received $1 million from the Pancreatic Cancer Action Network to develop better therapies for pancreatic cancer. http://www.fredhutch.org/en/news/center-news/2017/06/hutch-scientists-to-develop-bioassay-ovarian-cancer.html#hingorani

Post has attachment
This leukemia drug's story is worthy of a soap opera: Once hailed as the first so-called "magic bullet" drug, efficacy concerns led to its abrupt withdrawal from the market. Now, it is on the cusp of a comeback moment as a new study finds a 'home run' benefit for certain patients. Meet gemtuzumab ozogamicin, or Mylotarg.

Post has attachment
Jennifer Griffith, a highly regarded, longtime Washington, D.C., insider, has joined Fred Hutch as its vice president of Government Relations and Community Relations. From serving as chief of staff for a U.S. senator to planning and managing the Capitol Hill ceremonies of President Obama’s first Inauguration Day to working the halls of Congress as a lobbyist, she brings a depth of experience to her new role.

Post has attachment
“Clarity of purpose drew me to Fred Hutch,” said our new VP of Communications & Marketing Lynann Bradbury, who stepped into her role this week. “No matter where you sit in the organization or what role you play, you know the ultimate purpose here is to cure cancer.”

Post has attachment
In a tale of research going in unexpected directions, a team of evolutionary biologists has found that a gene family dubbed "wtf" can poison its own host. This so-called "selfish gene" yields no benefit to the host, a type of yeast, but may have driven the fungus's evolution.

Post has attachment
Learn more about how our doctors are reprogramming T-cells to make them stronger and better cancer "killing machines" in this new video featuring #immunotherapy Drs. David Maloney and Stan Riddell.

Post has attachment
There's a link between regular aspirin use and better survival for colorectal cancer survivors — but for whom? A new study sifts through a large population and finds the link holds up only for those with the most common tumor subtype.
Wait while more posts are being loaded